|
SNTB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.0285110237146E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33733041202322E-13 |
| Normal-vs-Stage2 |
3.21749960008333E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
3.33066907387547E-16 |
| Stage1-vs-Stage2 |
4.703000E-01 |
| Stage1-vs-Stage3 |
9.289600E-02 |
| Stage1-vs-Stage4 |
5.584300E-03 |
| Stage2-vs-Stage3 |
9.337800E-02 |
| Stage2-vs-Stage4 |
4.620000E-03 |
| Stage3-vs-Stage4 |
1.794210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.55031584528842E-15 |
| Normal-vs-AfricanAmerican |
5.6843999995948E-07 |
| Normal-vs-Asian |
2.1433999020104E-10 |
| Caucasian-vs-AfricanAmerican |
1.755820E-01 |
| Caucasian-vs-Asian |
5.778100E-02 |
| AfricanAmerican-vs-Asian |
9.594000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.0507154842071E-14 |
| Normal-vs-Female |
1.7000845176085E-12 |
| Male-vs-Female |
7.192000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.82200954113432E-13 |
| Normal-vs-Age(41-60Yrs) |
1.67821312402339E-12 |
| Normal-vs-Age(61-80Yrs) |
2.12052597703405E-14 |
| Normal-vs-Age(81-100Yrs) |
2.05239999995221E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.512800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.801020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.974300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.120200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.499980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.586010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.583310E-03 |
| Classical-VS-Follicular |
3.237600E-02 |
| Classical-VS-Other |
9.482000E-01 |
| Classical-VS-Normal |
2.16193729585257E-12 |
| Tall-VS-Follicular |
4.14090000000478E-05 |
| Tall-VS-Other |
1.662410E-01 |
| Tall-VS-Normal |
1.62525548574877E-12 |
| Follicular-VS-Other |
4.633800E-01 |
| Follicular-VS-Normal |
1.17490017714772E-10 |
| Other-VS-Normal |
9.632900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.99760216648792E-15 |
| N0-vs-N1 |
3.471700E-02 |
|
|
